Iovance Biotherapeutics (IOVA) Balance Sheet Annual - Discounting Cash Flows
Iovance Biotherapeutics, Inc.
IOVA (NASDAQ)

* (except for per share items) of USD
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
Report Filing: 2025-02-27 2024-02-28 2023-02-28 2022-02-24 2021-02-25 2020-02-25 2019-02-28 2018-03-12 2017-03-09 2016-03-11 2015-03-16 2014-03-28 2013-09-23 2012-03-30 2011-04-14 2010-03-31 2009-02-17
Total Current Assets 457 308 472 508 636 313 475 149 170 104 45.0 19.8 0.01 0.52 1.30 0.01 0.00
Cash and Short Term Investments 324 280 472 596 629 307 469 145 166 104 44.9 19.7 0.00 0.52 1.30 0.01 0.00
Cash & Equivalents 116 115 232 78.2 67.3 14.0 82.2 145 166 104 44.9 19.7 0.00 0.51 1.30 0.01 0.00
Short Term Investments 208 165 240 426 562 293 386 0.00 59.8 90.1 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Receivables 69.3 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory 51.5 10.4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Assets 12.4 17.5 0.00 -88.0 6.66 5.45 6.85 3.92 3.04 0.28 0.07 0.17 0.00 0.00 0.00 0.00 0.00
Total Assets 910 780 664 777 768 345 481 155 172 106 46.5 19.9 0.03 0.57 1.46 0.01 0.01
Total Non-Current Assets 453 473 6.43 269 132 32.1 5.45 6.08 2.37 1.68 1.53 0.03 0.02 0.04 0.16 0.00 0.00
Property, Plant and Equipment 164 177 178 170 114 19.2 2.68 2.45 2.37 1.68 1.53 0.03 0.02 0.03 0.16 0.00 0.00
Goodwill and Intangible Assets 282 229 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Intangible Assets 282 229 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.00 0.00
Long Term Investments 0.00 0.00 6.43 91.6 5.52 5.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Long Term Assets 6.73 66.7 -178 7.87 12.9 7.44 2.76 3.63 0.00 0.00 0.00 0.00 0.00 0.02 -0.16 0.00 0.00
Total Current Liabilities 122 110 91.5 89.2 54.9 39.1 14.4 9.89 4.97 1.63 1.66 2.27 11.3 13.3 0.82 0.02 0.00
Accounts Payable 27.5 33.1 26.6 27.4 13.5 15.6 2.74 1.23 0.86 0.96 1.25 0.41 1.10 0.19 0.03 0.00 0.00
Notes Payable/Short Term Debt 12.9 7.78 25.2 10.1 12.6 14.5 0.00 0.00 0.00 0.00 0.00 0.00 6.48 5.00 0.00 0.00 0.00
Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.00
Other Current Liabilities 81.9 69.4 39.7 51.7 28.8 9.01 11.7 8.66 4.11 0.67 0.41 1.86 3.77 7.94 0.79 0.02 0.00
Total Liabilities 200 196 164 156 112 45.7 14.6 9.89 4.97 1.63 1.66 2.27 11.3 13.3 0.82 0.02 0.00
Total Non-Current Liabilities 77.7 85.4 84.4 66.5 57.1 6.60 0.23 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long Term Debt 44.4 68.1 72.9 66.5 90.8 8.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax Liabilities Non-Current 32.3 17.3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital Lease Obligations 0.00 74.9 84.4 70.5 51.7 11.5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Long Term Liabilities 1.00 -74.9 -72.9 -70.5 -85.3 -13.4 0.23 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity 710 585 500 622 656 299 466 145 167 104 44.8 17.6 -11.3 -12.8 0.64 -0.01 0.00
Non-Controlling Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Stockholders' Equity 710 585 500 622 656 299 466 145 167 104 44.8 17.6 -11.3 -12.8 0.64 -0.01 0.00
Retained Earnings -2,385 -2,012 -1,568 -1,172 -830 -571 -373 -249 -157 -104 -76.6 -64.5 -30.7 -27.4 -1.68 -0.07 -0.06
Accumulated Other Earnings -1.05 2.53 -0.90 -0.60 0.02 0.22 -0.04 0.00 0.03 0.05 -0.10 -0.02 -0.01 0.00 0.00 0.00 0.00
Common Stock 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01
Preferred Stock 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional Paid in Capital 3,096 2,594 2,069 1,795 1,487 869 839 395 324 208 122 81.9 19.4 14.6 2.32 0.06 0.06
Total Liabilities & Total Equity 910 780 664 777 768 345 481 155 172 106 46.5 19.9 0.03 0.57 1.46 0.01 0.01
Total Liabilities & Shareholders' Equity 910 780 664 777 768 345 481 155 172 106 46.5 19.9 0.03 0.57 1.46 0.01 0.01
Total Investments 208 165 240 518 562 293 386 0.00 59.8 90.1 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Total Debt 57.3 75.9 84.4 71.5 51.7 11.5 0.00 0.00 0.00 0.00 0.00 0.00 6.48 5.00 0.00 0.00 0.00
Net Debt -58.4 -39.0 -147 -6.70 -15.7 -2.47 -82.2 -145 -166 -104 -44.9 -19.7 6.49 4.49 -1.30 -0.01 0.00
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us